Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1
Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Teresa Giménez(Bellvitge University Hospital), Jorge Sierra(Universitat Autònoma de Barcelona), Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert), Esther Alonso(Bellvitge University Hospital), Lourdes Florensa(Hospital Del Mar), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Esperanza Tuset(Hospital Del Mar), Anna Aventı́n(Hospital de Sant Pau), Marı́a Rozman(Universitat de Barcelona), Fuensanta Millá, Ana Garrido(Hospital de Sant Pau), Mireia Camós(Hospital Sant Joan de Déu Barcelona), Marina Díaz‐Beyá(Hospital Clínic de Barcelona), Marta Pratcorona(Hospital de Sant Pau), Leonor Arenillas(Hospital Del Mar), Mayda Navarrete(Vall d'Hebron Hospital Universitari), Esmeralda de la Banda(Bellvitge University Hospital), Granada Perea(Hospital Sant Joan de Déu Barcelona), Salut Brunet(Institut Català d'Oncologia), Blanca Navarro(Josep Carreras Leukaemia Research Institute)
Cited by 29
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k